Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 5, 2021
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
F Pommeret, J Colomba, C Bigenwald, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
C Dariane, C Pasqualini, N Gaspar, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 17, 2016
[CCAFU french national guidelines 2016-2018 on renal cancer]
K Bensalah, L Albiges, J-C Bernhard, et al.
ESMO Open
|
December 5, 2021
Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study
L Cerbone, D Combarel, A Geraud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
December 22, 2020
[French ccAFU guidelines - update 2020-2022: management of kidney cancer]
K Bensalah, P Bigot, L Albiges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 24, 2024
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Powles, L Albiges, A Bex, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 16, 2019
[French ccAFU guidelines - Update 2018-2020: Management of kidney cancer]
K Bensalah, L Albiges, J-C Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 27, 2018
RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : prise en charge du cancer du reinFrench ccAFU guidelines – Update 2018–2020: Management of kidney cancer
K Bensalah, L Albiges, J-C Bernhard, et al.
ESMO Open
|
April 27, 2023
Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma
J B A G Haanen, J Larkin, T K Choueiri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 16, 2022
Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting
L Mauge, L Phan, N Benhamouda, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 5, 2021
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
F Pommeret, J Colomba, C Bigenwald, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
C Dariane, C Pasqualini, N Gaspar, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 17, 2016
[CCAFU french national guidelines 2016-2018 on renal cancer]
K Bensalah, L Albiges, J-C Bernhard, et al.
ESMO Open
|
December 5, 2021
Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study
L Cerbone, D Combarel, A Geraud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
December 22, 2020
[French ccAFU guidelines - update 2020-2022: management of kidney cancer]
K Bensalah, P Bigot, L Albiges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 24, 2024
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Powles, L Albiges, A Bex, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 16, 2019
[French ccAFU guidelines - Update 2018-2020: Management of kidney cancer]
K Bensalah, L Albiges, J-C Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 27, 2018
RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : prise en charge du cancer du reinFrench ccAFU guidelines – Update 2018–2020: Management of kidney cancer
K Bensalah, L Albiges, J-C Bernhard, et al.
ESMO Open
|
April 27, 2023
Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma
J B A G Haanen, J Larkin, T K Choueiri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 16, 2022
Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting
L Mauge, L Phan, N Benhamouda, et al.
Page
of 7